Cytonics, an early-stage biopharmaceutical company developing therapies for osteoarthritis, today announced that the last ...

Post-traumatic osteoarthritis (PTOA) is a condition that affects joints after an injury. Current treatments focus on ...

Scientists at Queen Mary University of London have invented a new way to repair osteochondral defects – a common form of ...

Chondroitin sulfate may support bone health by boosting cartilage to reduce stress on the bones. Osteoarthritis often softens ...

Scientists have unveiled a revolutionary method for mass-producing high-quality human mitochondria, potentially transforming ...

Microparticle hydrogel shows clean systemic toxicity profile over 4 weeks and 13 weeks Treatment designed to restore ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis ...

Medically reviewed by David Ozeri, MD Tricompartmental osteoarthritis causes pain and damage due to the cartilage (cushioning ...

For patients that are refractory to the initial treatment plan, additional options include short term addition of amantadine, ...

Post-traumatic osteoarthritis (PTOA) is a condition that affects joints after an injury. Current treatments focus on relieving symptoms but do not prevent or stop the progression of the condition.

Microparticle hydrogel shows clean systemic toxicity profile over 4 weeks and 13 weeks Treatment designed to restore shock-absorbing capacities of joints in osteoarthritis Allegro plans to start ...